Loading...

Categories

29 Russia Pharmaceuticals Reports

Russia Diabetes Drugs Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: AstraZeneca, Eli Lilly, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis

Europe Insulin Drugs Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Biocon

DDP4 Inhibitors Industry in Europe

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: AstraZeneca, Takeda, Novartis, Merck & Co., Inc., Eli Lilly and Company

Europe GLP-1 Agonists Market

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, AstraZeneca, Eli lilly and Company, Sanofi, Pfizer

Europe Diabetes Drugs Industry

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Eli Lilly, Astrazeneca, Novo Nordisk, Sanofi, Boehringer Ingelheim

Europe Sodium-glucose Cotransporter 2 Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Janssen Pharmaceuticals, Eli Lilly and Company

Europe Biguanide Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Teva, Bristol-Myers Squibb, AstraZeneca, Sanofi Aventis, Merck and Co.

Europe GLP 1 Receptor Agonist Industry

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca, Biocon

Europe Meglitinide Industry

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Europe Alpha-Glucosidase Inhibitors Industry

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Europe Oral Anti-Diabetic Drug Market

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Sanofi, Eli Lilly, Astrazeneca, Astellas, Janseen

Insulin Market

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Diabetes Care Drugs Market

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

DPP4 Drugs Industry

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

GLP-1 Agonists Market

Country Covered: Russia

Study Period: 2019- 2029

Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Pfizer Inc.

Oral Antidiabetic Drugs Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca

Alpha Glucosidase Inhibitor Drugs Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

Biguanides Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Diabetes Combination Drugs Market

Country Covered: Russia

Study Period: 2019- 2029

Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S

Meglitinides Market

Country Covered: Russia

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Industry

Country Covered: Russia

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Glargine Insulin Market

Country Covered: Russia

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Wegovy Market

Country Covered: Russia

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S

Ozempic Market

Country Covered: Russia

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Liraglutide Market

Country Covered: Russia

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Injectable Anti-diabetic Drugs Market

Country Covered: Russia

Study Period: 2018-2029

Major Players: Novo Nordisk, Lilly, Julphar, Biocon, Sanofi

Trulicity Market

Country Covered: Russia

Study Period: 2021-2029

Major Players: Eli Lilly